- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00771940
Peripheral Metabolic Effects of Ghrelin
February 2, 2009 updated by: University of Aarhus
Peripheral Metabolic Effects of Intra Arterial Ghrelin Infusion in Healthy Controls
The aim of this study is to investigate putative peripheral effects of ghrelin on glucose and lipid metabolism in healthy men.
Eight subjects will be enrolled.
The hypothesis is that ghrelin infusion causes insulin resistance and lipolysis.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
8
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, Dk-8000
- Aarhus University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- BMI < 27 kg/m2
- Written informed consent
- Non-smoker
Exclusion Criteria:
- Any disease including epilepsy
- Any use of medications (excl. paracetamol)
- Present or previous malignancy
- Alcohol dependency
- Allergy to any trial medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Ghrelin
|
Solvent, cont. infusion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Plasma levels of glucose
Time Frame: During study day
|
During study day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Insulin signaling
Time Frame: Study day
|
Study day
|
Serum levels of fatty acids
Time Frame: Study day
|
Study day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jens Otto L. Jorgensen, MD, Medical Department M, Aarhus University Horpital, Denmark
- Principal Investigator: Esben T Vestergaard, PhD, Medical Department M, Aarhus University Hospital, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
January 1, 2009
Study Completion (Actual)
January 1, 2009
Study Registration Dates
First Submitted
October 8, 2008
First Submitted That Met QC Criteria
October 13, 2008
First Posted (Estimate)
October 15, 2008
Study Record Updates
Last Update Posted (Estimate)
February 3, 2009
Last Update Submitted That Met QC Criteria
February 2, 2009
Last Verified
February 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- M-2007008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Controls
-
University of ZurichCompleted
-
Hospices Civils de LyonCompleted
-
Massachusetts General HospitalCompletedHealthy ControlsUnited States
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS)Terminated
-
Centre for Addiction and Mental HealthUniversity Health Network, TorontoRecruiting
-
ElMindA LtdCompletedHealthy ControlsUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
University of FloridaCompletedHealthy ControlsUnited States
-
ElMindA LtdCompletedHealthy ControlsUnited States
-
University of ZurichCompletedHealthy ControlsSwitzerland
Clinical Trials on Ghrelin
-
Baker Heart and Diabetes InstituteCompleted
-
David DalessioNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Unknown
-
Jenny Tong, MD, MPHWithdrawn
-
Esben Thyssen VestergaardCompleted
-
University of PennsylvaniaCompleted
-
Hvidovre University HospitalCompletedBariatric SurgeryDenmark
-
Northwestern UniversityCompletedPeripheral Arterial Disease | Peripheral Artery Disease | PADUnited States
-
Lars LundCompletedHeart Failure With Reduced Ejection Fraction HFrEF
-
University of PennsylvaniaCompleted
-
Northwestern UniversityNational Institute on Aging (NIA)Recruiting